Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-09T02:16:15.601Z Has data issue: false hasContentIssue false

Prevalence of and factors associated with overweight and obesity in patients with severe mental disorders in Shenzhen: results from the urban Chinese population

Published online by Cambridge University Press:  07 November 2024

Wei Shan
Affiliation:
Affiliated Mental Health Center, Southern University of Science and Technology, Shenzhen, Guangdong, China Department of Public Health, Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
Zhijian Zhou
Affiliation:
Affiliated Mental Health Center, Southern University of Science and Technology, Shenzhen, Guangdong, China Department of Public Health, Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
Guojun Wang
Affiliation:
Affiliated Mental Health Center, Southern University of Science and Technology, Shenzhen, Guangdong, China Department of Public Health, Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
Xiaodong Peng*
Affiliation:
Department of Public Health, Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
*
*Corresponding author: Email xdpeng0726@163.com
Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the prevalence of overweight and obesity in patients with severe mental disorders (SMD) and the factors associated with their socio-demographic and disease characteristics in a cross-sectional population-based study.

Design:

This analysis examined the prevalence of overweight and obesity in 14 868 managed SMD patients in an urban area of Shenzhen city based on data from the health information monitoring system in 2021. Multivariate logistic regression were used to identify the factors associated with the prevalence of overweight and obesity in patients with SMD.

Setting:

China.

Participants:

14 868 patients with SMD.

Results:

The prevalence of overweight and obesity in patients with SMD in this study was 32·6 % and 16·1 %, respectively. In multivariate analysis, married status, Shenzhen household registration, management durations of 5–10 years and >10 years, participation in family physician services, taking clozapine or aripiprazole, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of overweight and obesity. Compared to their respective reference categories, living with parents, spouse and children, taking risperidone, aripiprazole, amisulpride and perphenazine, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of obesity.

Conclusion:

We observed a high prevalence of overweight and obesity in patients with SMD in this study. The findings highlight the need for integrated management of overweight and obesity risk factors among patients with SMD.

Information

Type
Research Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society
Figure 0

Table 1 Sociodemographic and physiological characteristics of the study population from 2006 to 2021

Figure 1

Table 2 Results of univariate logistic regression analysis for BMI

Figure 2

Fig. 1 Results of multiple logistic regression analysis for overweight and obesity. FPG, fasting plasma glucose; TC, serum total cholesterol; TG, triglyceride

Figure 3

Fig. 2 Results of multiple logistic regression analysis for obesity. FPG, fasting plasma glucose; TC, serum total cholesterol; TG, triglyceride